PDG10 COST-EFFECTIVENESS OF CELECOXIB VERSUS IBUPROFEN AND NAPROXEN IN PATIENTS WITH OSTEOARTHRITIS IN UNITED ARAB EMIRATES AND SAUDI ARABIA BASED ON RESULTS FROM THE PRECISION TRIAL
May 1, 2020, 00:00
10.1016/j.jval.2020.04.300
https://www.valueinhealthjournal.com/article/S1098-3015(20)30488-5/fulltext
Title :
PDG10 COST-EFFECTIVENESS OF CELECOXIB VERSUS IBUPROFEN AND NAPROXEN IN PATIENTS WITH OSTEOARTHRITIS IN UNITED ARAB EMIRATES AND SAUDI ARABIA BASED ON RESULTS FROM THE PRECISION TRIAL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30488-5&doi=10.1016/j.jval.2020.04.300
First page :
Section Title :
Open access? :
No
Section Order :
10162